JoVE Logo
Faculty Resource Center

Sign In

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

DOI :

10.3791/63696-v

October 6th, 2022

October 6th, 2022

2,031 Views

1Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles

This protocol describes a novel method to deliver oral combinational antiretroviral drugs that successfully suppress HIV-1 RNA replication in humanized mice.

Tags

Oral Combination Antiretroviral Treatment

-- Views

Related Videos

article

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

article

Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays

article

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

article

In vitro Uncoating of HIV-1 Cores

article

Imaging of HIV-1 Envelope-induced Virological Synapse and Signaling on Synthetic Lipid Bilayers

article

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

article

Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System.

article

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

article

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

article

Phagosome Migration and Velocity Measured in Live Primary Human Macrophages Infected with HIV-1

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved